Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.
Citation
Dulai PS, Siegel CA, Dubinsky MC. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013 Dec;19(13):2927-36.
Principal Investigator
Technology
Document Type
Research Method